Dr. Trevor J Simard, MD
Claim this profileMayo Clinic
Studies Heart Failure
Studies Radial Artery Occlusion
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Trevor J Simard, MD is currently running
Heart Surgery
for Coronary Artery Disease
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy (STICH3C) trial is a prospective, unblinded, international multi-center randomized trial of 754 subjects enrolled in approximately 45 centers comparing revascularization by percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in patients with multivessel/left main (LM) coronary artery disease (CAD) and reduced left ventricular ejection fraction (LVEF). The primary objective is to determine whether CABG compared to PCI is associated with a reduction in all-cause death, stroke, spontaneous myocardial infarction (MI), urgent repeat revascularization (RR), or heart failure (HF) readmission over a median follow-up of 5 years in patients with multivessel/LM CAD and ischemic left ventricular dysfunction (iLVSD). Eligible patients are considered by the local Heart Team appropriate and amenable for non-emergent revascularization by both modes of revascularization. The secondary objectives are to describe the early risks of both procedures, and a comprehensive set of patient-reported outcomes longitudinally.
Recruiting1 award N/A4 criteria
Rivaroxaban
for Radial Artery Occlusion
Transradial access (TRA) is the preferred vascular access site for invasive coronary angiography. TRA is limited by blockage of the radial artery post-procedurally, preventing future use of TRA. This is referred to as radial artery occlusion (RAO) and occurs in \~5% of cases. While intraprocedural anticoagulation has been studied extensively to mitigate this complication, oral anticoagulation post-TRA has not. The investigators will assess the impact of a one-week course of rivaroxaban post-TRA to reduce the rate of ultrasound-defined RAO at 30 days.
Recruiting2 awards Phase 32 criteria
More about Trevor J Simard, MD
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Trevor J Simard, MD has experience with
- Rivaroxaban
- Edwards Transcatheter Atrial Shunt System
- Edwards APTURE Transcatheter Shunt System
- Revascularization By CABG
- Revascularization By PCI
- Non-Vitamin K Oral Anticoagulant
Breakdown of trials Trevor J Simard, MD has run
Heart Failure
Radial Artery Occlusion
Iliac Artery Stenosis
Coronary Artery Disease
Cardiomyopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Trevor J Simard, MD specialize in?
Trevor J Simard, MD focuses on Heart Failure and Radial Artery Occlusion. In particular, much of their work with Heart Failure has involved treating patients, or patients who are undergoing treatment.
Is Trevor J Simard, MD currently recruiting for clinical trials?
Yes, Trevor J Simard, MD is currently recruiting for 3 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Trevor J Simard, MD has studied deeply?
Yes, Trevor J Simard, MD has studied treatments such as Rivaroxaban, Edwards Transcatheter Atrial Shunt System, Edwards APTURE Transcatheter Shunt System.
What is the best way to schedule an appointment with Trevor J Simard, MD?
Apply for one of the trials that Trevor J Simard, MD is conducting.
What is the office address of Trevor J Simard, MD?
The office of Trevor J Simard, MD is located at: Mayo Clinic, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.